# | Title | Journal | Year | Citations |
---|
1 | Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies | Cancer Journal (Sudbury, Mass ) | 2014 | 624 |
2 | Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial | Cancer Journal (Sudbury, Mass ) | 2001 | 566 |
3 | The Contribution of Angiogenesis to the Process of Metastasis | Cancer Journal (Sudbury, Mass ) | 2015 | 377 |
4 | Antibody-Drug Conjugates for Cancer Therapy | Cancer Journal (Sudbury, Mass ) | 2008 | 356 |
5 | A 14-Year Retrospective Review of Angiosarcoma | Cancer Journal (Sudbury, Mass ) | 2005 | 350 |
6 | Population Aging and Cancer | Cancer Journal (Sudbury, Mass ) | 2005 | 325 |
7 | What Is the Evidence That Palliative Care Teams Improve Outcomes for Cancer Patients and Their Families? | Cancer Journal (Sudbury, Mass ) | 2010 | 313 |
8 | Mechanisms of Resistance to PD-1 and PD-L1 Blockade | Cancer Journal (Sudbury, Mass ) | 2018 | 287 |
9 | Triple-Negative Breast Cancer | Cancer Journal (Sudbury, Mass ) | 2010 | 286 |
10 | Causes and Consequences of MicroRNA Dysregulation | Cancer Journal (Sudbury, Mass ) | 2012 | 260 |
11 | The Present and Future of Peptide Vaccines for Cancer | Cancer Journal (Sudbury, Mass ) | 2011 | 248 |
12 | The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease | Cancer Journal (Sudbury, Mass ) | 2012 | 242 |
13 | The Role of MicroRNAs in Colorectal Cancer | Cancer Journal (Sudbury, Mass ) | 2012 | 241 |
14 | Gene Signature in Melanoma Associated With Clinical Activity | Cancer Journal (Sudbury, Mass ) | 2010 | 232 |
15 | Contemporary Epidemiology of Renal Cell Cancer | Cancer Journal (Sudbury, Mass ) | 2008 | 231 |
16 | Diagnosis and Detection of Pancreatic Cancer | Cancer Journal (Sudbury, Mass ) | 2017 | 214 |
17 | Myeloid-Derived Suppressor Cells in Human Cancer | Cancer Journal (Sudbury, Mass ) | 2010 | 203 |
18 | The Role of the PI3K-AKT Pathway in Melanoma | Cancer Journal (Sudbury, Mass ) | 2012 | 197 |
19 | The Epidemiology of Cervical Cancer | Cancer Journal (Sudbury, Mass ) | 2003 | 196 |
20 | Microbiome, Inflammation, and Cancer | Cancer Journal (Sudbury, Mass ) | 2014 | 193 |
21 | Recovery Issues in Cancer Survivorship | Cancer Journal (Sudbury, Mass ) | 2006 | 190 |
22 | Physiologic Aspects of Aging | Cancer Journal (Sudbury, Mass ) | 2005 | 182 |
23 | Posttraumatic Stress and Posttraumatic Growth in Cancer Survivorship: A Review | Cancer Journal (Sudbury, Mass ) | 2008 | 182 |
24 | Breast Cancer During Pregnancy | Cancer Journal (Sudbury, Mass ) | 2010 | 180 |
25 | Hepatic Artery Embolization and Chemoembolization for Treatment of Patients with Metastatic Carcinoid Tumors | Cancer Journal (Sudbury, Mass ) | 2003 | 177 |
26 | Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma | Cancer Journal (Sudbury, Mass ) | 2012 | 176 |
27 | Oncolytic Virus Therapy for Glioblastoma Multiforme | Cancer Journal (Sudbury, Mass ) | 2012 | 175 |
28 | MicroRNAs | Cancer Journal (Sudbury, Mass ) | 2008 | 171 |
29 | CAR T Cells for Solid Tumors | Cancer Journal (Sudbury, Mass ) | 2014 | 170 |
30 | Prevalence of Human Papillomavirus in Oropharyngeal Cancer | Cancer Journal (Sudbury, Mass ) | 2015 | 168 |
31 | Indoleamine 2,3-Dioxygenase | Cancer Journal (Sudbury, Mass ) | 2010 | 162 |
32 | Mechanism of Cell Adaptation | Cancer Journal (Sudbury, Mass ) | 2011 | 162 |
33 | Basic Mechanisms of Therapeutic Resistance to Radiation and Chemotherapy in Lung Cancer | Cancer Journal (Sudbury, Mass ) | 2013 | 160 |
34 | Diet, the Gut Microbiome, and Epigenetics | Cancer Journal (Sudbury, Mass ) | 2014 | 158 |
35 | Sexual Health Communication During Cancer Care | Cancer Journal (Sudbury, Mass ) | 2009 | 157 |
36 | Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance | Cancer Journal (Sudbury, Mass ) | 2002 | 155 |
37 | The Biology of Brain Metastasis | Cancer Journal (Sudbury, Mass ) | 2015 | 152 |
38 | Viral Vector-Based Therapeutic Cancer Vaccines | Cancer Journal (Sudbury, Mass ) | 2011 | 151 |
39 | Biomarker-Driven Early Clinical Trials in Oncology | Cancer Journal (Sudbury, Mass ) | 2009 | 149 |
40 | Vitamin D: Considerations in the Continued Development as an Agent for Cancer Prevention and Therapy | Cancer Journal (Sudbury, Mass ) | 2010 | 149 |
41 | Image-Guided Radiofrequency Ablation of Spinal Tumors | Cancer Journal (Sudbury, Mass ) | 2002 | 147 |
42 | Biochemical Signaling of PD-1 on T Cells and Its Functional Implications | Cancer Journal (Sudbury, Mass ) | 2014 | 146 |
43 | Toll-Like Receptor Agonists | Cancer Journal (Sudbury, Mass ) | 2010 | 144 |
44 | Combinations of Bevacizumab With Cancer Immunotherapy | Cancer Journal (Sudbury, Mass ) | 2018 | 144 |
45 | Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer | Cancer Journal (Sudbury, Mass ) | 2010 | 142 |
46 | A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal Cancer | Cancer Journal (Sudbury, Mass ) | 2002 | 141 |
47 | Tissue microarray: a new technology for amplification of tissue resources | Cancer Journal (Sudbury, Mass ) | 2001 | 141 |
48 | Complementary Medicine in Palliative Care and Cancer Symptom Management | Cancer Journal (Sudbury, Mass ) | 2006 | 138 |
49 | Pancreatic Cancer, Inflammation, and Microbiome | Cancer Journal (Sudbury, Mass ) | 2014 | 137 |
50 | Epithelial Appendiceal Neoplasms | Cancer Journal (Sudbury, Mass ) | 2009 | 136 |